Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 3:25 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 457–480 of 1,410 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cardiovascular Function Clear all

Conditions: ST Elevation (STEMI) Myocardial Infarction of Anterior Wall
Interventions: CD-NP; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Worksite Health Promotion, Lifestyle Risk Reduction, Cardiovascular Diseases, Occupational Stress, Healthcare Workers
Interventions: WHHIP PLUS, Education only control; Behavioral
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Enrollment: 159 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Stroke, Cerebrovascular Disorders, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Vascular Diseases, Cardiovascular Diseases
Interventions: Aerobic Exercise, Upper Extremity Repetitive Task Practice; Behavioral
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 85 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Multiple Myeloma
Interventions: Lenalidomide, Dexamethasone, Elotuzumab (BMS-901608; HuLuc63); Drug · Biological
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 11
States / cities: Atlanta, Georgia • Indianapolis, Indiana • Iowa City, Iowa + 7 more

Conditions: Multiple Myeloma, Renal Insufficiency
Interventions: Carfilzomib; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 5
States / cities: San Francisco, California • Baltimore, Maryland • Detroit, Michigan + 2 more

Conditions: Cardiac Toxicity, Chemotherapeutic Agent Toxicity, Lymphoma
Interventions: contrast-enhanced magnetic resonance imaging; Procedure
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years to 120 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Heart Failure, Athletes Heart
Interventions: Not listed
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 89 Years
Enrollment: 80 participants
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Stroke
Interventions: Exercise; Procedure
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 40 Years to 85 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Posttraumatic Stress Disorder
Interventions: Cognitive processing therapy; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Congestive Heart Failure
Interventions: Carvedilol; Drug
Lead sponsor: Shaddy, Robert, M.D.; Individual
Eligibility: 1 Day to 17 Years
Enrollment: 75 participants
Timeline: 2002 – 2006
U.S. locations: 17
States / cities: Los Angeles, California • Palo Alto, California • Denver, Colorado + 13 more

Conditions: Stroke, Hand Function
Interventions: ReIn-Hand device assisted home-based practice; Device
Lead sponsor: Northwestern University; Other
Eligibility: 21 Years to 80 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Heart Failure
Interventions: Mesenchymal Precursor cells (RevascorTM), Cryoprotective media alone; Biological · Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 17
States / cities: San Diego, California • Washington D.C., District of Columbia • Oak Lawn, Illinois + 12 more

Conditions: Parkinson Disease, Autonomic Dysfunction
Interventions: Exercise Stress Test; Other
Lead sponsor: University of Miami; Other
Eligibility: 50 Years to 85 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Coral Gables, Florida

Conditions: Plasma Cell Myeloma
Interventions: Best Practice, Exercise Intervention, Quality-of-Life Assessment, Questionnaire Administration; Other
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Duarte, California

Conditions: Coronary Artery Disease
Interventions: Omacor (omega-3-acid ethyl esters); Drug
Lead sponsor: Olive View-UCLA Education & Research Institute; Other
Eligibility: 18 Years to 75 Years
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Sylmar, California

Conditions: Pulmonary Hypertension
Interventions: Not listed
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 17 Years to 90 Years
Enrollment: 119 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2021
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Peripheral Arterial Disease
Interventions: Beetroot Juice (Beet-It Stamina Shot) & Supervised Exercise Training, Placebo Comparator Beverage (Beet-It Stamina Shot) & Exercise Training; Drug · Other
Lead sponsor: Duke University; Other
Eligibility: 40 Years to 75 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Pulmonary Hypertension
Interventions: Telaglenastat; Drug
Lead sponsor: Chan, Stephen, MD, PhD; Other
Eligibility: 18 Years to 75 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Aortic Valve Stenosis
Interventions: Not listed
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Neurologic Diseases, Hemiparesis, Quadriplegia, Muscular Dystrophies, Arthrogryposis, Spinal Cord Injuries, Charcot-Marie-Tooth, Stroke, Weakness of Extremities as Sequela of Stroke, Weakness Due to Upper Motor Neuron Dysfunction, Amyotrophic Lateral Sclerosis, Spinal Muscular Atrophy, Arm Paralysis, Cerebral Palsy
Interventions: Neurosleeve; Device
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 4 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 2
States / cities: Wilmington, Delaware • Philadelphia, Pennsylvania

Conditions: Metabolic Syndrome, Hypertension
Interventions: 14 Nitrogen (N) Sodium Nitrite, Placebo; Drug
Lead sponsor: Gladwin, Mark, MD; Individual
Eligibility: 18 Years to 60 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Kidney Failure, Chronic, Heart Failure
Interventions: Empagliflozin 25 mg thrice-weekly post-hemodialysis dosing, Empagliflozin 10 mg daily dosing; Drug
Lead sponsor: University of Mississippi Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Jackson, Mississippi

Conditions: Left Ventricular Ejection Fraction, Heart Failure (HF), Left Bundle-Branch Block
Interventions: LB-CRT, BIV-CRT; Device
Lead sponsor: Inova Health Care Services; Other
Eligibility: Not listed
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Durham, North Carolina • Falls Church, Virginia

Conditions: Stress, Psychological, Sleep, Inflammation, Cardiovascular Diseases
Interventions: Mindfulness-Based Stress Reduction (MBSR); Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 87 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Durham, North Carolina

Search by objective public record fields.

CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular Function

Worksite Wellness Within Long-term Care Facilities

Cost-effectiveness of Forced Aerobic Exercise for Stroke Rehabilitation

Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function

Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function

Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin

Cardiopulmonary and Right Ventricular Function in Health and Disease

Treadmill Exercise Prescriptions to Improve Fitness Versus Ambulatory Function After Stroke.

Impact of Cognitive Behavioral Therapy on PTSD-CVD Link

Study to Evaluate the Safety of Twice Daily Oral Carvedilol

Development of a FES Device for Hand Use During Arm Activities Following Stroke

Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD

Parkinson's Autonomic Responses to Treadmill Walking

Telehealth Exercise Intervention to Improve Physical Function and Frailty in Multiple Myeloma Survivors

The Effect of Fish Oil Supplementation on Endothelial Function, Heart Rate Variability and Intimal Media Thickness of Patients With Coronary Artery Disease

Endothelial Function in Patients With Scleroderma or Cirrhosis With and Without Pulmonary Hypertension

Nitrites, Exercise, and Peripheral Arterial Disease

TEPH: Telaglenastat Efficacy in Pulmonary Hypertension

Defining Exercise Hemodynamics and Function After Transcatheter Aortic Valve Replacement (DEFINE-TAVR) Study.

NuroSleeve Powered Brace & Stimulation System to Restore Arm Function

Oral Nitrite Trial for Hypertension and Metabolic Syndrome

Empagliflozin in ESKD - A Feasibility Study

REsynchronization Comparison In LBBB and Normal or Mildly Reduced VENTricular Function With CRT (REINVENT-CRT)

Stress Reduction Training to Improve Sleep Quality, Stress Physiology & Cardiovascular Disease (CVD) Risk Markers